YY/T 1709-2020Evaluation of measurement uncertainty of calibrators for in vitro diagnostic kits (English PDF)
体外诊断试剂用校准物测量不确定度评定
This is a limited preview
Buy now to download the full PDF (30 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1709-2020 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
June 30, 2020
Implementation date
December 1, 2021
Scope
YY/T 1709-2020 is the English-translated version of 体外诊断试剂用校准物测量不确定度评定.
YY/T 1709-2020 is the Chinese pharmaceutical industry standard that explains how the measurement uncertainty of a calibrator for an in vitro diagnostic kit is evaluated.
It applies to the product calibrators of quantitative kits and follows the chain by which a value is assigned to them: the sources of uncertainty to be identified, how each component is estimated, how they are combined and expanded, and how the result is stated alongside the assigned value, so that the traceability claimed under GB/T 21415 can be supported with a number.
Manufacturers of kits and calibrators use it, as do the laboratories that verify their claims. Issued on 30 June 2020, it has applied since 1 December 2021.
Found what you need?
Document preview — YY/T 1709-2020
National Standard of the People's Republic of China
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword3
- 1 Scope4
- 2 Normative references4
- 3 Terms and definitions4
- 4 Evaluation process6
- 5 Uncertainty of changing batch of calibrator20
- Annex A (informative) Examples of uncertainty introduced by uniformity21
- Annex B (informative) Examples of uncertainty introduced by stability23
- Annex C (informative) Example of uncertainty evaluation introduced in process of valuing26
- Bibliography30
Foreword
This Standard was drafted in accordance with the rules given in GB/T 1.1-2009.
1 Scope
This Standard specifies evaluation methods of measurement uncertainty of calibrators for in vitro diagnostic kits.
This Standard is applicable to evaluation of measurement uncertainty of product calibrators for in vitro diagnostic quantitative kits.
2 Normative references
The following referenced documents are indispensable for the application of this document. For dated references, only the edition cited applies. For undated references, the latest edition of the referenced document (including any amendments) applies.
GB/T 21415, In vitro diagnostic medical devices - Measurement of quantities in biological samples - Metrological traceability of values assigned to calibrators and control materials
3 Terms and definitions
For the purposes of this document, the following terms and definitions apply.
3.1 Product calibrator; calibrator
The calibrator intended for the manufacturer's final product.
3.2 Working calibrator; master calibrator
Measurement standard used for calibration of manufacturer's permanent measurement procedures.
3.3 Metrological traceability
The characteristic of linking measurement results with references through a documented uninterrupted calibration chain. Every calibration introduces measurement uncertainty.
3.4 Measurement uncertainty; uncertainty
Non-negative parameter that characterize the dispersion given to measured value, according to the information used. [GB/T 29791.1-2013, definition A.3.35]
3.5 Target uncertainty; maximum allowable measurement uncertainty
The specified upper limit of the measurement uncertainty based on the intended use of the measurement result.
4 Evaluation process
4.1 General
4.1.1 Basic flow
According to the flow shown in Figure 1, evaluate the measurement uncertainty of in vitro diagnostic calibrator.
4.1.2 Amount of being measured and target uncertainty
The manufacturer shall specify the amount of being measured, including the intended use of the amount in a specific medical decision, biological sample matrix and any type and unit of measurement related to the analyzed component, amount.
4.1.3 Sources of uncertainty
See Figure 2 for evaluation of measurement uncertainty sources of calibrators for in vitro diagnostic kits. The measurement uncertainty introduced by uniformity and stability as well as the uncertainty related to the setting process together constitute the main component of the measurement uncertainty of the calibrator.
4.1.4 Uncertainty evaluation strategy
The scheme proposed in this Standard is a non-restrictive scheme. Other reasonable schemes can be used to evaluate the uncertainty of the calibrator.
4.2 Measurement uncertainty introduced by uniformity, ubb
4.2.1 General
The product calibrators for in vitro diagnostic kits are usually produced in batches. The measurement uncertainty ubb introduced by the uniformity between bottles within a batch, constitutes an important component of the uncertainty of the calibrator.
4.2.2 Test scheme
4.2.2.1 Test method
The test method shall meet the following requirements.
4.2.2.2 Sample extraction
According to random stratification method, extract the calibrator from the smallest packaging unit for uniformity inspection. Number the samples in sequence, for example, 1, 2,..., 15.
4.2.2.3 Testing
Each packaging unit is respectively measured at least 3 times. Considering the fluctuation of the measurement system over time and other factors, it needs to reverse the sequence of samples between 3 measurements, for example, 1-3- 5-7-9-11-13-15-2-4-6-8-10-12-14-15-14-13-12-11-10-9-8-7-6-5-4-3-2-1-2-4-6- 8-10-12-14-1-3-5-7-9-11-13-15.
4.3 Measurement uncertainty introduced by stability, us
4.3.1 General
The stability of the calibrator includes long-term stability and short-term stability.
Long-term stability is the storage stability under the conditions specified by the manufacturer. Short-term stability includes transportation stability and use stability (for example, involving multiple sampling). Generally, the measurement uncertainty introduced by long-term stability, ults, constitutes an important component of the uncertainty of the calibrator. The measurement uncertainty introduced by short-term stability, usts, shall also be considered when it is not negligible.
4.6 Uncertainty reporting and evaluation
When the user needs it, the manufacturer shall provide the user with the uncertainty of the calibrator assignment and be able to provide the uncertainty component results and uncertainty evaluation process.
5 Uncertainty of changing batch of calibrator
Usually the calibrator needs to re-evaluate the uncertainty.
If the historical batch data of uncertainty component or combined uncertainty is used, the following conditions must be met.
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 30 pages — is available in the English PDF.
Referenced standards
Similar standards
How to Download YY/T 1709-2020
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 21415-2008 — In vitro diagnostic medical devices - Measurement of quantities in biological samples - Metrological traceability of values assigned to calibrators and control materials
GB/T 21415-2025 — In vitro diagnostic medical devices - Requirements for establishing metrological traceability of values assigned to calibrators, trueness control materials and human samples
YY/T 0297-2026 — General requirements for clinical investigation of medical devices
Secure payment via Stripe
Payments accepted
YY/T 1709-2020
$305.00